carbon monoxide has been researched along with Idiopathic Interstitial Pneumonia in 7 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lung diffusing capacity for carbon monoxide (DLCO) is decreased in both usual interstitial pneumonia-idiopathic pulmonary fibrosis (UIP-IPF) and nonspecific interstitial pneumonia (NSIP), but is moderately related to computed tomography (CT)-determined fibrotic changes." | 3.83 | Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias. ( Barisione, G; Baroffio, M; Brusasco, C; Brusasco, V; Garlaschi, A, 2016) |
| "This study aimed to investigate the disease progression and mortality of patients with CTD-ILD and idiopathic interstitial pneumonias (IIP) including idiopathic pulmonary fibrosis (IPF) and idiopathic nonspecific interstitial pneumonia and the prognostic impact of the radiological UIP pattern on both disease groups." | 1.51 | Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias. ( Bitik, B; Erbaş, G; Haznedaroğlu, Ş; Köktürk, N; Türk, M; Türktaş, H; Yıldırım, F, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vaszar, LT | 1 |
| Larsen, BT | 1 |
| Swanson, KL | 1 |
| Ryu, JH | 1 |
| Tazelaar, HD | 1 |
| Yıldırım, F | 1 |
| Türk, M | 1 |
| Bitik, B | 1 |
| Erbaş, G | 1 |
| Köktürk, N | 1 |
| Haznedaroğlu, Ş | 1 |
| Türktaş, H | 1 |
| Flaherty, KR | 1 |
| Fell, C | 1 |
| Aubry, MC | 1 |
| Brown, K | 1 |
| Colby, T | 1 |
| Costabel, U | 1 |
| Franks, TJ | 1 |
| Gross, BH | 1 |
| Hansell, DM | 1 |
| Kazerooni, E | 1 |
| Kim, DS | 1 |
| King, TE | 1 |
| Kitachi, M | 1 |
| Lynch, D | 1 |
| Myers, J | 1 |
| Nagai, S | 1 |
| Nicholson, AG | 1 |
| Poletti, V | 1 |
| Raghu, G | 1 |
| Selman, M | 1 |
| Toews, G | 1 |
| Travis, W | 1 |
| Wells, AU | 1 |
| Vassallo, R | 1 |
| Martinez, FJ | 1 |
| Barisione, G | 1 |
| Brusasco, C | 1 |
| Garlaschi, A | 1 |
| Baroffio, M | 1 |
| Brusasco, V | 1 |
| Chartrand, S | 1 |
| Swigris, JJ | 1 |
| Stanchev, L | 1 |
| Lee, JS | 1 |
| Brown, KK | 2 |
| Fischer, A | 1 |
| Liang, M | 1 |
| Jiang, Z | 1 |
| Huang, Q | 1 |
| Liu, L | 1 |
| Xue, Y | 1 |
| Zhu, X | 1 |
| Yu, Y | 1 |
| Wan, W | 1 |
| Yang, H | 1 |
| Zou, H | 1 |
| Yang, IV | 1 |
| Luna, LG | 1 |
| Cotter, J | 1 |
| Talbert, J | 1 |
| Leach, SM | 1 |
| Kidd, R | 1 |
| Turner, J | 1 |
| Kummer, N | 1 |
| Kervitsky, D | 1 |
| Boon, K | 1 |
| Schwarz, MI | 1 |
| Schwartz, DA | 1 |
| Steele, MP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19[NCT04610554] | 74 participants (Actual) | Observational | 2020-05-14 | Completed | |||
| Lung Diffusing Capacity for Nitric Oxide as a Marker of Fibrotic Changes in Idiopathic Interstitial Pneumonias[NCT02596841] | 60 participants (Actual) | Observational | 2013-02-28 | Completed | |||
| Mechanisms of Pulmonary Diffusion Limitation in Systemic Sclerosis[NCT03601520] | 100 participants (Actual) | Observational | 2014-03-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for carbon monoxide and Idiopathic Interstitial Pneumonia
| Article | Year |
|---|---|
Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF).
Topics: Aged; Autoimmune Diseases; Blood Sedimentation; Carbon Monoxide; Chemokine CXCL1; Female; Humans; Id | 2016 |
6 other studies available for carbon monoxide and Idiopathic Interstitial Pneumonia
| Article | Year |
|---|---|
Diagnostic utility of surgical lung biopsies in elderly patients with indeterminate interstitial lung disease.
Topics: Aged; Aged, 80 and over; Biopsy; Carbon Monoxide; Female; Humans; Idiopathic Interstitial Pneumonias | 2018 |
Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Topics: Aged; Carbon Monoxide; Disease Progression; Female; Forced Expiratory Volume; Humans; Idiopathic Int | 2019 |
Smoking-related idiopathic interstitial pneumonia.
Topics: Adult; Aged; Carbon Monoxide; Female; Humans; Idiopathic Interstitial Pneumonias; International Coop | 2014 |
Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
Topics: Aged; Biomarkers; Carbon Monoxide; Female; Humans; Idiopathic Interstitial Pneumonias; Lung; Male; N | 2016 |
Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
Topics: Aged; Biomarkers; Carbon Monoxide; Female; Humans; Idiopathic Interstitial Pneumonias; Lung; Male; N | 2016 |
Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
Topics: Aged; Biomarkers; Carbon Monoxide; Female; Humans; Idiopathic Interstitial Pneumonias; Lung; Male; N | 2016 |
Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
Topics: Aged; Biomarkers; Carbon Monoxide; Female; Humans; Idiopathic Interstitial Pneumonias; Lung; Male; N | 2016 |
Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
Topics: Aged; Biomarkers; Carbon Monoxide; Female; Humans; Idiopathic Interstitial Pneumonias; Lung; Male; N | 2016 |
Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
Topics: Aged; Biomarkers; Carbon Monoxide; Female; Humans; Idiopathic Interstitial Pneumonias; Lung; Male; N | 2016 |
Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
Topics: Aged; Biomarkers; Carbon Monoxide; Female; Humans; Idiopathic Interstitial Pneumonias; Lung; Male; N | 2016 |
Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
Topics: Aged; Biomarkers; Carbon Monoxide; Female; Humans; Idiopathic Interstitial Pneumonias; Lung; Male; N | 2016 |
Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
Topics: Aged; Biomarkers; Carbon Monoxide; Female; Humans; Idiopathic Interstitial Pneumonias; Lung; Male; N | 2016 |
Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience.
Topics: Adrenal Cortex Hormones; Adult; Amino Acyl-tRNA Synthetases; Antibodies, Antinuclear; Autoimmune Dis | 2016 |
The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis.
Topics: Aged; Biomarkers; Carbon Monoxide; Case-Control Studies; Disease Progression; Female; Gene Expressio | 2012 |